Central to Collate's new capabilities is the launch of AI Studio, which enables enterprises to build, deploy, customize, and tune AI agents to their unique data environments. AI Studio provides a ...

AI tools are fundamentally changing software development. Investing in foundational knowledge and deep expertise secures your career long-term.

Indonesia's construction market is poised for growth driven by state-led initiatives in residential affordability and urbanization, a focus on digital infrastructure in commercial projects, strategic ...

Learn how frameworks like Solid, Svelte, and Angular are using the Signals pattern to deliver reactive state without the ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

A powerful 5.8 magnitude earthquake struck south of Java, Indonesia, at 1806 GMT Thursday, with its epicenter at 9.09°S 111.17°E and a shallow 10 km depth, according to GFZ German Research Centre.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

11Institute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 12Liangzhu Laboratory, Zhejiang University ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...